Anti-Blood group A sugar determinant [9A]
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (6)
- Inventor Info
Info
![Image thumbnail for Anti-Blood group A sugar determinant [9A]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/891380bb-3b39-4cec-8e4b-81313b9393a6.jpg)
| Catalogue Number | 151066 |
| Applications | ELISA FACS IHC IP |
| Antigen/Gene or Protein Targets | Blood group A sugar determinant |
| Reactivity | Human |
| Relevance | 9A is suitable for binding to the EGF receptor in A431 cells only. These cells have a glycosylation defect which reveals otherwise cryptic sugar structures. |
| Host | Mouse |
| Immunogen | A431 cells (human vulval squamous carcinoma cell line) |
| Subclass | IgG3 |
| Myeloma Used | P3X63Ag8 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Notes | Not to be used as an EGF receptor specific reagent. |
| Research Area | Cell Type or Organelle Marker |
References: 6 entries
Increased a-series gangliosides positively regulate leptin/Ob receptor-mediated signals in hypothalamus of GD3 synthase-deficient mice.
Europe PMC ID: 27644882
Fischer et al. 2015. Front Immunol. 6:211. PMID: 25999949.
FACS
Gullick et al. 1990. J Pathol. 162(3):275-6. PMID: 2266467.
'EGF receptor' antibody 29.1.1.
Europe PMC ID: 2266467
Parker et al. 1984. J Biol Chem. 259(15):9906-12. PMID: 6086658.
IP
Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor.
Europe PMC ID: 6086658
Add a reference
References: 6 entries
Increased a-series gangliosides positively regulate leptin/Ob receptor-mediated signals in hypothalamus of GD3 synthase-deficient mice.
Fischer et al. 2015. Front Immunol. 6:211. PMID: 25999949.
FACS
Gullick et al. 1990. J Pathol. 162(3):275-6. PMID: 2266467.
'EGF receptor' antibody 29.1.1.
Parker et al. 1984. J Biol Chem. 259(15):9906-12. PMID: 6086658.
IP
Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor.
Add a reference
